Allscripts Healthcare Solutions Inc Stock Nasdaq
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
|
May. 29 | Veradigm to Explore Strategic Alternatives | CI |
May. 28 | Veradigm Inc. Is Reaffirms Earnings Guidance for Fiscal 2024 | CI |
Financials (USD)
Sales 2022 * | 617M | Sales 2023 * | 622M | Capitalization | 1.66B |
---|---|---|---|---|---|
Net income 2022 * | -4M | Net income 2023 * | 53M | EV / Sales 2022 * | 1.57 x |
Net cash position 2022 * | 692M | Net cash position 2023 * | 728M | EV / Sales 2023 * | 1.5 x |
P/E ratio 2022 * |
-493
x | P/E ratio 2023 * |
25.6
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 * |
-
| Free-Float | 38.22% |
Latest transcript on Allscripts Healthcare Solutions Inc
Managers | Title | Age | Since |
---|---|---|---|
Thomas Langan
CEO | Chief Executive Officer | 58 | 17-12-31 |
Director of Finance/CFO | 55 | Dec. 06 | |
Rick Dipper
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Rodriguez
BRD | Director/Board Member | 60 | 23-02-16 |
Jonathan Judge
BRD | Director/Board Member | 70 | 16-05-23 |
David Stevens
BRD | Director/Board Member | 62 | 16-05-23 |
1st Jan change | Capi. | |
---|---|---|
-2.39% | 30.38B | |
+37.51% | 9.35B | |
+35.03% | 4.45B | |
-40.39% | 2.26B | |
-29.44% | 1.22B | |
-41.27% | 1.01B | |
-6.21% | 840M | |
-49.31% | 707M | |
-28.49% | 632M |